Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
Clinical Investigation of the Safety and Performance of HiRes Ultra Cl HiFocus MS Electrode (Cl-1600-04) and HiRes Ultra 3D Cl HiFocus MS Electrode (Cl-1601-04) (Ultra X Implants) in Adults With Severe-to-profound Hearing Loss
1 other identifier
observational
30
1 country
3
Brief Summary
This is a prospective study designed to evaluate the safety and performance of the HiRes Ultra Cl HiFocus MS Electrode and HiRes Ultra 3D Cl HiFocus MS Electrode (Ultra X) under normal conditions of use as it is approved for this device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2020
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2020
CompletedFirst Submitted
Initial submission to the registry
September 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 21, 2025
CompletedResults Posted
Study results publicly available
March 25, 2026
CompletedMarch 25, 2026
February 1, 2026
4.7 years
September 22, 2020
February 16, 2026
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Freiburger Monosyllables Score in Quiet
score in % correct (scale from 0 to 100% of correct answers)
6 months
Secondary Outcomes (1)
Speech Reception Theshold (SRT) in Noise
6 months
Interventions
patients receive a cochlear implantation within clinical routine
Eligibility Criteria
30 adult subjects with valid and useable data
You may qualify if:
- No previous experience with any auditory implant
- years of age or older
- Postlingual onset of severe hearing loss (≥ 4 years of age)
- Limited benefit from appropriately fitted hearing aids, defined as scoring 60% or less in Freiburger Monosyllabic word test
- German language proficiency
- Willingness to participate in all scheduled procedures outlined in the protocol
You may not qualify if:
- Cochlear malformation or obstruction that would preclude full insertion of electrode array.
- Presence of additional disabilities that would prevent or interfere with participation in the required study procedures
- Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study related procedures
- Evidence of central auditory lesion or compromised auditory nerve
- Pregnancy at time of surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Heilig Geist Hospital Bensheim
Bensheim, Hesse, 64625, Germany
Unfallkrankenhaus Berlin (UKB
Berlin, State of Berlin, 12683, Germany
Klinik für HNO-Heilkunde. Kopf- imd Halschirurgie
Mannheim, 68167, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Caroline-Marie DELATTRE
- Organization
- Advanced Bionics
Study Officials
- PRINCIPAL INVESTIGATOR
Arneborg Ernst, Prof. Dr.
Unfallkrankenhaus Berlin
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2020
First Posted
October 30, 2020
Study Start
September 16, 2020
Primary Completion
May 21, 2025
Study Completion
May 21, 2025
Last Updated
March 25, 2026
Results First Posted
March 25, 2026
Record last verified: 2026-02